W. Neunteufel

发表

Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference.

M. Gnant, P. Lukas, C. Marth, 2012, Geburtshilfe und Frauenheilkunde.

Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.

G. Breitenecker, W. Neunteufel, 1989, Gynecologic Oncology.

Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients.

P. Speiser, C. Kainz, A. Obermair, 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Does hysteroscopy facilitate tumor cell dissemination?

A. Kaider, C. Kainz, A. Obermair, 2000, Cancer.

Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.

P. Speiser, C. Kainz, A. Obermair, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

CA 125 in the follow-up of patients with ovarian cancer.

C. Bieglmayer, H. Koelbl, W. Neunteufel, 1988, European journal of obstetrics, gynecology, and reproductive biology.

CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma.

G. Breitenecker, W. Neunteufel, 1989, Cancer letters.

Rates and Routes of Hysterectomy for Benign Indications in Austria 2002 – 2014

P. Reif, K. Tamussino, G. Fülöp, 2017, Geburtshilfe und Frauenheilkunde.

CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading

C. Bieglmayer, G. Breitenecker, W. Neunteufel, 2004, Archives of Gynecology and Obstetrics.

Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer

M. Micksche, M. Vetterlein, G. Breitenecker, 1989 .

Squamous cell carcinoma (SCC) antigen in patients with invasive cervical carcinoma during primary irradiation.

C. Bieglmayer, W. Neunteufel, G. Tatra, 1990, Gynecologic and obstetric investigation.

p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.

G. Heinze, N. Hacker, G. Gitsch, 1998, Gynecologic oncology.

Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.

N. Hacker, M. Friedlander, D. Bancher-Todesca, 1998, Gynecologic oncology.

Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.

H. Kölbl, G. Gitsch, G. Breitenecker, 1989, Anticancer research.

Chlamydophila abortus Pelvic Inflammatory Disease

H. Hotzel, M. Dierich, R. Würzner, 2003, Emerging infectious diseases.

Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg

F. Petraglia, L. Anttila, J. Marr, 2011, Clinical drug investigation.

Verrucous Carcinoma of the Endometrium: A Rare and Challenging Diagnosis

F. Offner, W. Sterlacci, R. Stockinger, 2014, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

MCA, a monoclonal-antibody-defined breast-tumor-associated antigen and its relation to CA 15.3.

C. Bieglmayer, T. Szepesi, W. Neunteufel, 1989, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.

C. Bieglmayer, T. Szepesi, W. Neunteufel, 1988, Cancer letters.

Wertheim radical hysterectomy 1921–1986: Changes in urologic complications

H. Koelbl, P. Riss, W. Neunteufel, 2004, Archives of Gynecology and Obstetrics.

Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls

C. Bieglmayer, W. Neunteufel, G. Tatra, 2004, Archives of Gynecology and Obstetrics.

The significance of determining CA 15-3 in the cytosol of breast cancer

C. Bieglmayer, C. Dadak, W. Neunteufel, 2005, Journal of Cancer Research and Clinical Oncology.

Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors.

H. Kölbl, C. Bieglmayer, G. Breitenecker, 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer.

L. Hefler, C. Tempfer, G. Gitsch, 1999, Anticancer research.

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.

L. Hefler, C. Tempfer, G. Gitsch, 1999, Anticancer research.